6,570
Views
27
CrossRef citations to date
0
Altmetric
Perspective

Life-course immunization as a gateway to health

ORCID Icon, , , &
Pages 851-864 | Received 24 Apr 2018, Accepted 20 Sep 2018, Published online: 23 Oct 2018

References

  • He W, Goodkind D, Kowal P. An Aging World: 2015 - International Population Reports [Internet]. Washington (DC): U.S. Census Bureau. [cited 21 Sep 2017]. Available from: https://www.census.gov/content/dam/Census/library/publications/2016/demo/p95-16-1.pdf.
  • Centers for Disease Control and Prevention (CDC). Ten great public health achievements–United States, 1900-1999. MMWR Morb Mortal Wkly Rep. 1999;48(12):241–243.
  • Delany I, Rappuoli R, De Gregorio E. Vaccines for the 21st century. EMBO Mol Med. 2014;6(6):708–720.
  • Thomas-Crusells J, McElhaney JE, Aguado MT. Report of the ad-hoc consultation on aging and immunization for a future WHO research agenda on life-course immunization. Vaccine. 2012;30(42):6007–6012.
  • Doherty M, Schmidt-Ott R, Santos JI, et al. Vaccination of special populations: protecting the vulnerable. Vaccine. 2016;34(52):6681–6690.
  • World Health Organization. Active Ageing: A Policy Framework [Internet]. Geneva (Switzerland): World Health Organization. [cited 14 Feb 2018]. Available from: http://apps.who.int/iris/bitstream/10665/67215/1/WHO_NMH_NPH_02.8.pdf.
  • Gavazzi G, Krause KH. Ageing and infection. Lancet Infec Dis. 2002;2(11):659–666.
  • Goronzy JJ, Weyand CM. Understanding immunosenescence to improve responses to vaccines. Nat Immunol. 2013;14(5):428–436.
  • Garau J, Hodin MW, Kalache A. Life-course immunization: a driver of healthy aging [Internet]. The Global Coalition on Aging. [cited 15 Sep 2017]. Available from: https://globalcoalitiononaging.com/wp-content/uploads/2018/07/life-course-immunization_gcoa-for-web-1.pdf
  • World Health Organization. Global vaccine action plan 2011-2020 [Internet]. Geneva (Switzerland): World Health Organization. [cited 10 Mar 2017]. Available from: http://www.who.int/immunization/global_vaccine_action_plan/GVAP_doc_2011_2020/en/
  • Weinberger B. Adult vaccination against tetanus and diphtheria: the European perspective. Clin Exp Immunol. 2017;187(1):93–99.
  • Steeper M, Plebanski M, Flanagan KL. The global challenge and future strategies for keeping the world’s aging population healthy by vaccination. Trans R Soc Trop Med Hyg. 2016;110(8):427–431.
  • National Vaccine Advisory Committee. A pathway to leadership for adult immunization: recommendations of the National Vaccine Advisory Committee: approved by the National Vaccine Advisory Committee on June. 14, 2011. Public Health Rep. 2012;127(Suppl 1):1–42.
  • National Prevention Council. Healthy Aging in Action [Internet]. Washington (DC): U.S. Department of Health and Human Services, Office of the Surgeon General. [cited 4 Dec 2017]. Available from: https://www.cdc.gov/aging/pdf/healthy-aging-in-action508.pdf
  • Ali KA, Celentano LP. Finding the balance in life-course immunization. Eurohealth. 2016;22(3):22–32.
  • World Health Organization. European Immunization Week 2017 [Internet]. Geneva (Switzerland): World Health Organization. [cited 15 Sep 2017]. Available from: http://www.euro.who.int/en/media-centre/events/events/2017/04/european-immunization-week-2017
  • Bonanni P, Chiamenti G, Conforti G, et al. The 2016 lifetime immunization schedule approved by the Italian scientific societies: a new paradigm to promote vaccination at all ages. Hum Vaccin Immunother. 2017;13(11): 2531–2537.
  • Signorelli C, Iannazzo S, Odone A. The imperative of vaccination put into practice. Lancet Infec Dis. 2018;18(1):26–27.
  • Burioni R, Odone A, Signorelli C. Lessons from Italy’s policy shift on immunization. Nature. 2018;555(7694):30.
  • Signorelli C, Guerra R, Siliquini R, et al. Italy’s response to vaccine hesitancy: an innovative and cost effective national immunization plan based on scientific evidence. Vaccine. 2017;35(33):4057–4059.
  • Lévy-Bruhl D, Desenclos J-C, Quelet S, et al. Extension of French vaccination mandates: from the recommendation of the steering committee of the citizen consultation on vaccination to the law. Euro Surveill. 2018;23(17):pii=18-00048. Available from: https://doi.org/10.2807/1560-7917.ES.2018.23.17.18-00048
  • Yang YT, Studdert DM. Linking Immunization Status and. Eligibility for welfare and benefits payments: the Australian “No Jab, No Pay” legislation. JAMA. 2017;317(8):803–804.
  • Kanitz EE, Wu LA, Giambi C, et al. Variation in adult vaccination policies across Europe: an overview from VENICE network on vaccine recommendations, funding and coverage. Vaccine. 2012;30(35):5222–5228.
  • Sanderson W, Scherbov S. Rethinking age and aging. Popul Bull. 2008;63(4):3–16.
  • Crews DE, Zavotka S. Aging, disability, and frailty: implications for universal design. J Physiol Anthropol. 2006;25(1):113–118.
  • World Health Organization. Vaccines against influenza WHO position paper - November 2012. Releve Epidemiologique hebdomadaire/Section D’hygiene Du Secretariat De La Societe Des Nations = Weekly Epidemiological record/Health Section of the Secretariat of the League of Nations. 2012;87(47):461–476.
  • ACIP Adult Immunization Work Group, Bridges CB, Woods L, Coyne-Beasley T. Centers for disease control and prevention. Advisory Committee on Immunization Practices (ACIP) recommended immunization schedule for adults aged 19 years and older–United States, 2013. MMWR Supplements. 2013;62(1):9–19.
  • Kim DK, Riley LE, Harriman KH, et al. Advisory committee on immunization practices recommended immunization schedule for adults aged 19 years or older - United States, 2017. MMWR Morb Mortal Wkly Rep. 2017;66(5):136–138.
  • Department of Health. Immunise Australia Program - Older Australians [Internet]. Canberra (ACT): Australian Government. [cited 15 Nov 2017]. Available from: http://www.immunise.health.gov.au/internet/immunise/publishing.nsf/Content/older-australians
  • National Health Service. NHS vaccination schedule [Internet]. London (UK): National Health Service. [cited 13 Nov 2017]. Available from: https://www.nhs.uk/Conditions/vaccinations/Pages/vaccination-schedule-age-checklist.aspx
  • European Centre for Disease Prevention and Control. Seasonal influenza vaccination in Europe vaccination recommendations and coverage rates in the EU member states for eight influenza seasons: 2007–2008 to 2014–2015 [Internet]. Stockholm: ECDC. [cited 13 Nov 2017]. Available from: https://ecdc.europa.eu/sites/portal/files/documents/influenza-vaccination-2007%E2%80%932008-to-2014%E2%80%932015.pdf
  • Chlibek R, Smetana J, Pauksens K, et al. Safety and immunogenicity of three different formulations of an adjuvanted varicella-zoster virus subunit candidate vaccine in older adults: a phase II, randomized, controlled study. Vaccine. 2014;32(15):1745–1753.
  • Leroux-Roels I, Leroux-Roels G, Clement F et al. A phase 1/2 clinical trial evaluating safety and immunogenicity of a varicella zoster glycoprotein E subunit vaccine candidate in young and older adults. J Infect Dis. 2012;206(8):1280–1290.
  • Lal H, Cunningham AL, Godeaux O, et al. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N Engl J Med. 2015;372(22):2087–2096.
  • Cunningham AL, Lal H, Kovac M, et al. Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older. N Engl J Med. 2016;375(11):1019–1032.
  • Chu HY, Englund JA. Maternal immunization. Clin Infect Dis. 2014;59(4):560–568.
  • Bethancourt CN, Wang TL, Bocchini JA Jr. Vaccination during pregnancy: first line of defense for expecting mothers and vulnerable young infants. Curr Opin Pediatr. 2017;29(6):737–743.
  • Swamy GK, Heine RP. Vaccinations for pregnant women. Obstet Gynecol. 2015;125(1):212–226.
  • Regan AK. The safety of maternal immunization. Hum Vaccin Immunother. 2016;12(12):3132–3136.
  • Lahra MM, Enriquez RP. Australian Meningococcal Surveillance Programme annual report, 2015. Commun Dis Intell Q Rep. 2016;40(4):E503–E511.
  • Vyse A, Ellsbury G, Madhava H. Protecting UK adolescents and adults against meningococcal serogroup B disease. Expert Rev Vaccines. 2018;17(3):229–237.
  • Rose KC. Adolescent vaccines: latest recommendations, addressing barriers, and improving vaccine rates. NASN Sch Nurse. 2017;32(4):217–222.
  • World Health Organization. Tetanus vaccine. WHO position paper. Releve Epidemiologique hebdomadaire/Section D’hygiene Du Secretariat De La Societe Des Nations = Weekly Epidemiological record/Health Section of the Secretariat of the League of Nations. 2006;81(20):198–208.
  • World Health Organization. Pertussis vaccines: WHO position paper - September 2015. Releve Epidemiologique hebdomadaire/Section D’hygiene Du Secretariat De La Societe Des Nations = Weekly Epidemiological record/Health Section of the Secretariat of the League of Nations. 2015;90(35):433–458.
  • World Health Organization. Diphtheria vaccines: WHO position paper. Releve Epidemiologique hebdomadaire/Section D’hygiene Du Secretariat De La Societe Des Nations = Weekly Epidemiological record/Health Section of the Secretariat of the League of Nations. 2006;81(3):21–32.
  • Houser K, Subbarao K. Influenza vaccines: challenges and solutions. Cell Host Microbe. 2015;17(3):295–300.
  • World Health Organization. Measles vaccines: WHO position paper - April 2017. Releve Epidemiologique hebdomadaire/Section D’hygiene Du Secretariat De La Societe Des Nations = Weekly Epidemiological record/Health Section of the Secretariat of the League of Nations. 2017;92(17):205–227.
  • Patel MK, Gacic-Dobo M, Strebel PM, et al. Progress toward regional measles elimination - worldwide, 2000-2015. MMWR Morb Mortal Wkly Rep. 2016;65(44):1228–1233.
  • Fine PEM, Mulholland K. Community immunity. In: Plotkin SA, Orenstein WA, Offit PA, editors. Vaccines. 6th Edition ed. Philadelphia, United States: Elsevier/Saunders; 2013. p. 1395–1412.
  • Centers for Disease Control and Prevention. CDC glossary [Internet]. Atlanta (GA): CDC. [cited 11 Sep 2017]. Available from: https://www.cdc.gov/vaccines/terms/glossary.html
  • Kim TH, Johnstone J, Loeb M. Vaccine herd effect. Scand J Infect Dis. 2011;43(9):683–689.
  • Centers for Disease Control and Prevention. Direct and indirect effects of routine vaccination of children with. 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease–United States, 1998-2003. MMWR Morb Mortal Wkly Rep. 2005;54(36):893–897.
  • Fitzwater SP, Chandran A, Santosham M, et al. The worldwide impact of the seven-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2012;31(5):501–508.
  • Attwell K, Smith DT, Ward PR. ‘The Unhealthy Other’: how vaccine rejecting parents construct the vaccinating mainstream. Vaccine. 2018;36(12):1621–1626.
  • Attwell K, Smith DT. Parenting as politics: social identity theory and vaccine hesitant communities. Int J Health Governance. 2017;22(3):183–198.
  • Teresa Aguado M, Barratt J, Beard JR, et al. Report on WHO meeting on immunization in older adults: Geneva, Switzerland, 22-23 March 2017. Vaccine. 2018;36(7):921–931.
  • MacDonald NE. Vaccine hesitancy: definition, scope and determinants. Vaccine. 2015;33(34):4161–4164.
  • Philip RK, Shapiro M, Paterson P, et al. Is it time for vaccination to “Go Viral”? Pediatr Infect Dis J. 2016;35(12):1343–1349.
  • Milkman KL, Beshears J, Choi JJ, et al. Using implementation intentions prompts to enhance influenza vaccination rates. Proc Natl Acad Sci U S A. 2011;108(26):10415–10420.
  • Bedford H, Attwell K, Danchin M, et al. Vaccine hesitancy, refusal and access barriers: the need for clarity in terminology. Vaccine. 2017;pii: S0264-410X(17)31070-8. doi: 10.1016/j.vaccine.2017.08.004.
  • Betsch C, Brewer NT, Brocard P, et al. Opportunities and challenges of web 2.0 for vaccination decisions. Vaccine. 2012;30(25):3727–3733.
  • Forkner-Dunn J. Internet-based patient self-care: the next generation of health care delivery. J Med Internet Res. 2003;5(2):e8.
  • Pias-Peleteiro L, Cortes-Bordoy J, Martinon-Torres F. Google: what about the human papillomavirus vaccine? Hum Vaccin Immunother. 1712-1719;9(8):2013.
  • Kata A. Anti-vaccine activists, web 2.0, and the postmodern paradigm–an overview of tactics and tropes used online by the anti-vaccination movement. Vaccine. 2012;30(25):3778–3789.
  • Aquino F, Donzelli G, De Franco E, et al. The web and public confidence in MMR vaccination in Italy. Vaccine. 2017;35(35): 4494–4498.
  • Betsch C, Renkewitz F, Betsch T, et al. The influence of vaccine-critical websites on perceiving vaccination risks. J Health Psychol. 2010;15(3):446–455.
  • Kata A. A postmodern Pandora’s box: anti-vaccination misinformation on the Internet. Vaccine. 2010;28(7):1709–1716.
  • McCartney M. Margaret McCartney: evidence in a post-truth world. BMJ. 2016;355:i6363.
  • Fine P, Eames K, Dl H. “Herd immunity”: a rough guide. Clin Infect Dis. 2011;52(7):911–916.
  • Buttenheim AM, Asch DA. Making vaccine refusal less of a free ride. Hum Vaccin Immunother. 2013;9(12):2674–2675.
  • Benin AL, Wisler-Scher DJ, Colson E, et al. Qualitative analysis of mothers’ decision-making about vaccines for infants: the importance of trust. Pediatrics. 2006;117(5):1532–1541.
  • Reich J. Neoliberal mothering and vaccine refusal: imagined gated communities and the privilege of choice. Gend Soc. 2014;28(5):679–704.
  • Sobo EJ. What is herd immunity. How Does It Relate to Pediatric Vaccination Uptake? US Parent Perspectives. Soc Sci Med. 2016;165:187–195.
  • Hershley JC, Asch DA, Thumasathit T, et al. The roles of altruism, free riding, and bandwagoning in vaccination decisions. Organ Behav Hum Decis Process. 1994;59(2):177–187.
  • Ndeffo Mbah ML, Liu J, Bauch CT, et al. The impact of imitation on vaccination behavior in social contact networks. PLoS Comput Biol. 2012;8(4):e1002469.
  • Williams WW, Lu PJ, O’Halloran A, et al. Surveillance of vaccination coverage among adult populations - United States, 2015. MMWR Surveill Summ. 2017;66(11):1–28.
  • Tan L. Adult vaccination: now is the time to realize an unfulfilled potential. Hum Vaccin Immunother. 2015;11(9):2158–2166.
  • Tin Tin Htar M, Stuurman AL, Ferreira G, et al. Effectiveness of pneumococcal vaccines in preventing pneumonia in adults, a systematic review and meta-analyses of observational studies. PLoS One. 2017;12(5):e0177985.
  • Norris T, Vahratian A, Cohen RA. Vaccination coverage among adults aged 65 and over: United States, 2015. NCHS Data Brief. 2017;281:1–8.
  • Bonanni P, Ferro A, Guerra R, et al. Vaccine coverage in Italy and assessment of the 2012-2014 National Immunization Prevention Plan. Epidemiol Prev. 2015;39(4 Suppl 1):146–158.
  • Jorgensen P, Mereckiene J, Cotter S, et al. How close are countries of the WHO European region to achieving the goal of vaccinating 75% of key risk groups against influenza? Results from national surveys on seasonal influenza vaccination programmes, 2008/2009 to 2014/2015. Vaccine. 2018;36(4):442–452.
  • Ding H, Black CL, Ball S et al. Influenza vaccination coverage among pregnant women - United States, 2016-17 Influenza season. MMWR Morb Mortal Wkly Rep. 2017;66(38):1016–1022.
  • Kerr S, Van Bennekom CM, Liang JL, et al. Tdap vaccination coverage during pregnancy - selected sites, United States, 2006-2015. MMWR Morb Mortal Wkly Rep. 2017;66(41):1105–1108.
  • Walker TY, Elam-Evans LD, Singleton JA, et al. National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years - United States, 2016. MMWR Morb Mortal Wkly Rep. 2017;66(33):874–882.
  • Gahr P, DeVries AS, Wallace G, et al. An outbreak of measles in an undervaccinated community. Pediatrics. 2014;134(1):e220–228.
  • Carrillo-Santisteve P, Lopalco PL. Measles still spreads in Europe: who is responsible for the failure to vaccinate? Clin Microbiol Infect. 2012;18(Suppl 5):50–56.
  • Dabbagh A, Patel MK, Dumolard L, et al. Progress toward regional measles elimination - worldwide, 2000-2016. MMWR Morb Mortal Wkly Rep. 2017;66(42):1148–1153.
  • Dube E, Gagnon D, Nickels E, et al. Mapping vaccine hesitancy–country-specific characteristics of a global phenomenon. Vaccine. 2014;32(49):6649–6654.
  • de Gomensoro E, Del Giudice G, Doherty TM. Challenges in adult vaccination. Ann Med. 2018;50(3):181–192.
  • Yaqub O, Castle-Clarke S, Sevdalis N, et al. Attitudes to vaccination: a critical review. Soc Sci Med. 2014;112:1–11.
  • Opel DJ, Heritage J, Taylor JA, et al. The architecture of provider-parent vaccine discussions at health supervision visits. Pediatrics. 2013;132(6):1037–1046.
  • Smith PJ, Kennedy AM, Wooten K, et al. Association between health care providers’ influence on parents who have concerns about vaccine safety and vaccination coverage. Pediatrics. 2006;118(5):e1287–1292.
  • Holm MV, Blank PR, Szucs TD. Developments in influenza vaccination coverage in England, Scotland and wales covering five consecutive seasons from 2001 to 2006. Vaccine. 2007;25(46):7931–7938.
  • Collins J, Alona I, Tooher R, et al. Increased awareness and health care provider endorsement is required to encourage pregnant women to be vaccinated. Hum Vaccin Immunother. 2014;10(10):2922–2929.
  • Maher L, Hope K, Torvaldsen S, et al. Influenza vaccination during pregnancy: coverage rates and influencing factors in two urban districts in Sydney. Vaccine. 2013;31(47):5557–5564.
  • Arden NH. Control of influenza in the long-term-care facility: a review of established approaches and newer options. Infect Control Hosp Epidemiol. 2000;21(1):59–64.
  • Kroger AT, Atkinson WL, Marcuse EK, et al. General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2006;55(RR–15):1–48.
  • Maltezou HC, Poland GA. Immunization of health-care providers: necessity and public health policies. Healthcare (Basel). 2016;4:3.
  • Black CL, Yue X, Ball SW, et al. Influenza vaccination coverage among health care personnel - United States, 2016-17 Influenza Season. MMWR Morb Mortal Wkly Rep. 2017;66(38):1009–1015.
  • Srivastav A, Black CL, Lu PJ, et al. Tdap vaccination among healthcare personnel, internet panel survey, 2012-2014. Am J Prev Med. 2017;53(4):537–546.
  • Hofmann F, Ferracin C, Marsh G, et al. Influenza vaccination of healthcare workers: a literature review of attitudes and beliefs. Infection. 2006;34(3):142–147.
  • Jiang C, Whitmore-Sisco L, Gaur AH, et al. A quality improvement initiative to increase Tdap (tetanus, diphtheria, acellular pertussis) vaccination coverage among direct health care providers at a children’s hospital. Vaccine. 2018;36(2):214–219.
  • Ridda I, Lindley R, MacIntyre RC. The challenges of clinical trials in the exclusion zone: the case of the frail elderly. Australas J Ageing. 2008;27(2):61–66.
  • Mitnitski AB, Mogilner AJ, Rockwood K. Accumulation of deficits as a proxy measure of aging. Sci World J. 2001;1:323–336.
  • Roberts JN, Gruber MF. Regulatory considerations in the clinical development of vaccines indicated for use during pregnancy. Vaccine. 2015;33(8):966–972.
  • de Martino M. Dismantling the taboo against vaccines in pregnancy. Int J Mol Sci. 2016;17:6.
  • Streefland P, Chowdhury AM, Ramos-Jimenez P. Patterns of vaccination acceptance. Soc Sci Med. 1999;49(12):1705–1716.
  • Seeber L, Michl B, Rundblad G, et al. A design thinking approach to effective vaccine safety communication. Curr Drug Saf. 2015;10(1):31–40.
  • Herath C, Zhou Y, Gan Y, et al. A comparative study of interprofessional education in global health care: a systematic review. Medicine. 2017;96(38):e7336.
  • Drozd EM, Miller L, Johnsrud M. Impact of pharmacist immunization authority on seasonal influenza immunization rates across states. Clin Ther. 2017;39(8):1563–1580 e1517.
  • Harris K, Maurer J, Black C, et al. Workplace efforts to promote influenza vaccination among healthcare personnel and their association with uptake during the 2009 pandemic influenza A (H1N1). Vaccine. 2011;29(16):2978–2985.
  • Jacobson Vann JC, Szilagyi P. Patient reminder and patient recall systems to improve immunization rates. Cochrane Database Syst Rev. 2005;3:CD003941.
  • Larson HJ, Cooper LZ, Eskola J, et al. Addressing the vaccine confidence gap. Lancet. 2011;378(9790):526–535.
  • Ozawa S, Stack ML. Public trust and vaccine acceptance–international perspectives. Hum Vaccin Immunother. 2013;9(8):1774–1778.
  • Murakami H, Kobayashi M, Hachiya M, et al. Refusal of oral polio vaccine in northwestern Pakistan: a qualitative and quantitative study. Vaccine. 2014;32(12):1382–1387.
  • Jegede AS. What led to the Nigerian boycott of the polio vaccination campaign? PLoS Med. 2007;4(3):e73.
  • Oubari H, Tuttle R, Rath B, et al. Communicating vaccine safety to the media and general public. Curr Drug Saf. 2015;10(1):80–86.
  • Hardt K, Schmidt-Ott R, Glismann S, et al. Sustaining vaccine confidence in the 21st century. Vaccines. 2013;1(3):204–224.
  • World Health Organization. Vaccination and trust library [Internet]. Geneva (Switzerland): World Health Organization. [cited 21 Sep 2017]. Available from: http://www.euro.who.int/en/health-topics/disease-prevention/vaccines-and-immunization/publications/vaccination-and-trust
  • Muzumdar JM, Pantaleo NL. Comics as a medium for providing information on adult immunizations. J Health Commun. 2017;22(10):783–791.
  • Diamond J, McQuillan J, Spiegel AN, et al. Viruses, vaccines and the public. Mus Soc Issues. 2016;11(1):9–16.
  • Brewer NT, Chapman GB, Gibbons FX, et al. Meta-analysis of the relationship between risk perception and health behavior: the example of vaccination. Health Psychol. 2007;26(2):136–145.
  • Ropeik D. How society should respond to the risk of vaccine rejection. Hum Vaccin Immunother. 2013;9(8):1815–1818.
  • Signorelli C, Iannazzo S, Odone A. The imperative of vaccination put into practice. Lancet Infect Dis. 2018;18(1):26–27.
  • Pianigiani G. Proof of children’s vaccinations? Italy will now take parents’ word for it [Internet]. New York City (NY): The New York Times. [cited 05 Aug 2018]. Available from: https://www.nytimes.com/2018/07/05/world/europe/italy-vaccines.html
  • Laws are not the only way to boost immunization. Nature. 2018;553(7688):249–250.
  • Rodriguez-Fernandez R, Martinez-Lopez AB, Perez-Moreno J, et al. Impact of an influenza vaccine educational programme on healthcare personnel. Epidemiol Infect. 2016;144(11):2290–2294.
  • Danchin MH, Costa-Pinto J, Attwell K, et al. Vaccine decision-making begins in pregnancy: correlation between vaccine concerns, intentions and maternal vaccination with subsequent childhood vaccine uptake. Vaccine. 2017;pii: S0264-410X(17)31069-1. doi: 10.1016/j.vaccine.2017.08.003.
  • Quadri-Sheriff M, Hendrix KS, Downs SM, et al. The role of herd immunity in parents’ decision to vaccinate children: a systematic review. Pediatrics. 2012;130(3):522–530.
  • Standaert BA, Rappuoli R. How is the economic assessment of vaccines performed today? J Mark Access Health Policy. 2017;5(1):1335163.
  • Lu PJ, O’Halloran A, Ding H, et al. Uptake of influenza vaccination and missed opportunities among adults with high-risk conditions, United States, 2013. Am J Med. 2016;129(6):636e1–636e11.
  • Hyle EP, Rao SR, Jentes ES, et al. Missed opportunities for measles, mumps, rubella vaccination among departing U.S. adult travelers receiving pretravel health consultations. Ann Intern Med. 2017;167(2):77–84.
  • Link-Gelles R, Chamberlain AT, Schulkin J, et al. Missed opportunities: a national survey of obstetricians about attitudes on maternal and infant immunization. Matern Child Health J. 2012;16(9):1743–1747.
  • Subbarao K, Matsuoka Y. The prospects and challenges of universal vaccines for influenza. Trends Microbiol. 2013;21(7):350–358.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.